46th Annual Scientific Meeting
2026 Keynote Speakers
We are pleased to announce the first speakers for our upcoming conference, featuring a distinguished lineup of experts in dermapathology.
Bringing together leading clinicians, pathologists, and researchers, the program will showcase the latest advancements in diagnostic techniques, clinicopathological correlations, emerging technologies, and complex case discussions. Our speakers will deliver valuable insights that bridge dermatology and pathology, supporting best practice and innovation across the field.
This is a unique opportunity to learn from and engage with those shaping the future of dermapathology.
Jeffrey P. North, MD
Managing Director & Professor of Pathology and Dermatology
After finishing undergraduate studies in molecular biology and chemistry at Brigham Young University, I attended medical school at UCSF from 2002 to 2006. As a first-year medical student, I began working with Boris Bastian, M.D., on melanoma genetics, studying the evolution of melanoma on acral (hands/feet) skin. My interest in dermatology grew during my time at UCSF, leading to a dermatology residency at Oregon Health & Science University, where I served as chief resident from 2009 to 2010. I returned to UCSF in 2010 for a Dermatopathology fellowship, followed by a year on faculty as a clinical instructor. After one year on faculty at the University of Missouri as the director of dermatopathology, I rejoined the faculty on the UCSF Dermatopathology and Oral Pathology Service and am delighted to be a member of such an outstanding academic and clinical dermatology and dermatopathology unit.
My interests include increasing diagnostic precision in both inflammatory and neoplastic dermatologic conditions. This includes utilizing molecular techniques such as fluorescent in situ hybridization (FISH) and comparative genomic hybridization (CGH) to better characterize histopathologically ambiguous melanocytic tumors and provide better prognostic information for patients based on cancer-related changes in the tumor genome. I am also interested in immunoprofiling inflammatory skin diseases to allow for more precise diagnosis and understanding of these diseases. In addition, I enjoy teaching and mentoring students, residents, and fellows rotating through our service.
Artur Zembowicz, M.D., Ph.D.
Founder, Medical Director, and Principal Consultant at Dermatopathology Consultations, LLC, and Founder of Dermpedia.org
Dr. Zembowicz received his M.D. and Ph.D. (Pharmacology) degrees from Copernicus Academy of Medicine/Jagiellonian University Medical College in Krakow, Poland. His basic research involved inflammation and vascular biology and included training in the laboratory of Sir John R. Vane, FRS, a Nobel Prize Laureate, at the William Harvey Research Institute in London, UK, and research fellowships at the Department of Hematology at the UT Houston with Dr. Kenneth K. Wu, M.D, at Harvard with Dr. Michael Gimbrone, M.D. This experience is the basis of his interest in inflammatory dermatopathology, especially vasculitis, vasculopathies, and drug eruptions.
Dr. Zembowicz trained in Anatomic Pathology at the Brigham and Women's Hospital in Boston, a teaching hospital of Harvard Medical School. At the Brigham, he studied dermatopathology with Dr. Raymond Barnhill and Dr. Phillip McKee. After completing the Harvard Dermatopathology Fellowship in 1999, he joined Dr. Martin C. Mihm as his associate in Dr. Mihm’s Consultation Practice and, in 2000, the Department of Pathology at the Massachusetts General Hospital in Boston. Between 2000 and 2007, he served as an Attending Physician on the Dermatopathology, Head and neck pathology (with Drs. Ben Z. Pilch, M.D., and William Faquin, M.D.), and Ophthalmic pathology (with Drs. Thaddeus Dryja, M.D., and Frederic Jacobiec, M.D.) services at the Massachusetts General Hospital and Massachusetts Eye and Ear Infirmary in Boston.